Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters
- Standort
-
Deutsche Nationalbibliothek Frankfurt am Main
- ISSN
-
1661-4917
- Umfang
-
Online-Ressource
- Sprache
-
Englisch
- Anmerkungen
-
online resource.
- Erschienen in
-
Anti-tumor action of tumor necrosis factor against Bomirski Ab melanoma in hamsters ; volume:55 ; number:4 ; day:23 ; month:7 ; year:2007 ; pages:267-279 ; date:08.2007
Archivum immunologiae et therapiae experimentalis ; 55, Heft 4 (23.7.2007), 267-279, 08.2007
- Urheber
-
Koszałka, Patrycja
Szmit, Ewa
Myśliwski, Andrzej
Bigda, Jacek
- Beteiligte Personen und Organisationen
-
SpringerLink (Online service)
- DOI
-
10.1007/s00005-007-0031-9
- URN
-
urn:nbn:de:101:1-2021061719484188703225
- Rechteinformation
-
Open Access; Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Letzte Aktualisierung
-
14.08.2025, 10:59 MESZ
Datenpartner
Dieses Objekt wird bereitgestellt von:
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Deutsche Nationalbibliothek. Bei Fragen zum Objekt wenden Sie sich bitte an den Datenpartner.
Beteiligte
- Koszałka, Patrycja
- Szmit, Ewa
- Myśliwski, Andrzej
- Bigda, Jacek
- SpringerLink (Online service)
Ähnliche Objekte (12)
Golimumab: A Novel Anti-Tumor Necrosis Factor
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Novel therapeutic strategies and modulators of anti-tumor immunity in melanoma
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma
Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 −/− mice
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway
Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study
Golimumab: A Novel Anti-Tumor Necrosis Factor
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Novel therapeutic strategies and modulators of anti-tumor immunity in melanoma
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma
Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 −/− mice
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway
Factors that influence rheumatologists’ anti-tumor necrosis factor alpha prescribing decisions: a qualitative study
Golimumab: A Novel Anti-Tumor Necrosis Factor
Anti-tumor necrosis factor therapy in inflammatory bowel disease : 15 tables
Update on intravitreal anti-tumor necrosis factor alpha therapies for ocular disorders
Novel therapeutic strategies and modulators of anti-tumor immunity in melanoma
Stat3-mediated Atg7 expression regulates anti-tumor immunity in mouse melanoma
Successful treatment of Cronkhite–Canada syndrome using anti-tumor necrosis factor antibody therapy
Successful treatment with anti-tumor necrosis factor alpha for reactive small-bowel amyloidosis
HDAC6 selective inhibition of melanoma patient T-cells augments anti-tumor characteristics
Gut microbiota dependent anti-tumor immunity restricts melanoma growth in Rnf5 −/− mice
Targeted Anti‐Tumor Immunotherapy Using Tumor Infiltrating Cells
Maslinic acid potentiates the anti-tumor activity of tumor necrosis factor α by inhibiting NF-κB signaling pathway